Pentagastrin
五肽胃泌素
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NamePentagastrin
Drug Alias Name +[10]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1974/07/26
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A
Develop Information
Active CompaniesShanghai Livzon Pharmaceutical Co Ltd
Inactive CompaniesWyeth-Ayerst
Active Indications
Inactive IndicationsN/A